First, management factors In daily management, it is forbidden to violently whip pregnant cows, drastically drive away or allow them to jump across the ditch, so as to prevent cows from causing abortion due to excessive movement. Second, empty factors Practice has proved that the longer cows empty time, the higher the probability of abortion. In production, we must pay attention to the control of the graze of pregnant cows and empty cows, and feed more green and juicy feed to prevent infertility and miscarriage. Third, the younger the age of the initial match, the higher the incidence of miscarriage. In production, the initial age of young cattle should be controlled to be over 17 months of age and weigh between 355 and 375 kg. In addition, it is necessary to strengthen the management of pregnant cows, provide full-priced compound feed and enough green and juicy feed. Fourth, disease factors Cows suffering from uterine disease are prone to miscarriage, production should strengthen the feeding and management, to promote the recovery of postpartum cows uterus, timely prevention and treatment of uterine diseases. Cows that have had two consecutive miscarriages should be considered for elimination. V. Feeding factors The milk abortion rate was higher for pregnant women aged 3 to 5 months, and abortion rate was lower for 2 months before pregnancy. Therefore, it is imperative to strengthen the management of early and mid-term pregnant cows, and it is forbidden to feed poor-quality, mildewed, and frozen feeds.
Ziprasidone Intermediates
Ziprasidone is a medication of the atypical antipsychotic type. It is used for the treatment of schizophrenia as well as acute mania and mixed states associated with bipolar disorder. Its intramuscular injection form is approved for acute agitation in people with schizophrenia. Ziprasidone is also used off-label for depression, bipolar maintenance, and posttraumatic stress disorder.
Ziprazidone is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia as well as acute mania and mixed states associated with bipolar disorder. Its intramuscular injection form is approved for acute agitation in schizophrenic patients for whom treatment with just ziprasidone is appropriate.
We produce a series of complete intermediates for Ziprasidone, intermediate I (CAS No. 2634-33-5) and intermediate II (CAS No. 7716-66-7) etc.
All of our products are with stable production and strict quality control, making sure your experience with Sunshine Biotech is always enriching, satisfying and fulfilling.
Ziprasidone Intermediates
Ziprasidone Intermediates,Cas 7716-66-7 ,Cas 2634-33-5,Ziprasidone Hydrochloride Intermediate
Nanjing Sunshine Biotech Co., Ltd , https://www.sunshine-bio.com